Mydecine Innovations Company Top Insiders
MYCOF Stock | USD 0 0 28.00% |
Mydecine Innovations employs about 11 people. The company is managed by 8 executives with a total tenure of roughly 26 years, averaging almost 3.0 years of service per executive, having 1.38 employees per reported executive. Examination of Mydecine Innovations' management performance can provide insight into the company performance.
Sanford Stein Insider Gen Officer |
Damon Michaels Insider CoFounder COO |
Mydecine |
Mydecine Innovations Management Team Effectiveness
The company has return on total asset (ROA) of (1.7615) % which means that it has lost $1.7615 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.244) %, meaning that it generated substantial loss on money invested by shareholders. Mydecine Innovations' management efficiency ratios could be used to measure how well Mydecine Innovations manages its routine affairs as well as how well it operates its assets and liabilities.Mydecine Innovations Workforce Comparison
Mydecine Innovations Group is regarded fourth in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 2,338. Mydecine Innovations adds roughly 11.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Mydecine Innovations Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Mydecine Innovations Price Series Summation is a cross summation of Mydecine Innovations price series and its benchmark/peer.
Mydecine Innovations Notable Stakeholders
A Mydecine Innovations stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mydecine Innovations often face trade-offs trying to please all of them. Mydecine Innovations' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mydecine Innovations' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sanford Stein | Gen Officer | Profile | |
Damon Michaels | CoFounder COO | Profile | |
Robert MA | Chief CoFounder | Profile | |
William Cook | Interim Inc | Profile | |
Morgan Kervitsky | Director Marketing | Profile | |
Michel Rudolphie | Pres Operations | Profile | |
David Bartch | CEO, CoFounder | Profile | |
MD FRCPC | Chief Officer | Profile |
About Mydecine Innovations Management Performance
The success or failure of an entity such as Mydecine Innovations often depends on how effective the management is. Mydecine Innovations management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mydecine management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mydecine management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Mydecine Innovations operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11 people.
Mydecine Innovations Workforce Analysis
Traditionally, organizations such as Mydecine Innovations use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mydecine Innovations within its industry.Mydecine Innovations Manpower Efficiency
Return on Mydecine Innovations Manpower
Revenue Per Employee | 681 | |
Revenue Per Executive | 937 | |
Net Loss Per Employee | 2.6M | |
Net Loss Per Executive | 3.6M |
Complementary Tools for Mydecine Pink Sheet analysis
When running Mydecine Innovations' price analysis, check to measure Mydecine Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mydecine Innovations is operating at the current time. Most of Mydecine Innovations' value examination focuses on studying past and present price action to predict the probability of Mydecine Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mydecine Innovations' price. Additionally, you may evaluate how the addition of Mydecine Innovations to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |